This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Buy Soaring Chewy Stock Before Q3 Earnings as E-Commerce Play?
by Benjamin Rains
Chewy (CHWY) is an e-commerce pet store that has expanded into telehealth and bolstered its pet medication offerings...
Zacks Industry Outlook Highlights: Teladoc, PRA Health and DexCom
by Zacks Equity Research
Zacks Industry Outlook Highlights: Teladoc, PRA Health and DexCom
IoMT Meets New Healthcare Needs: 3 MedTech Trends to Watch
by Urmimala Biswas
Medical device which has for long taken tiny steps toward IoMT is now going all out to make the most of the advancements in this space amid the pandemic.
3 Healthcare Stocks to Keep Gaining From Telehealth Services
by Srijita Guha
Amid the coronavirus pandemic, we pick three healthcare stocks that are poised to grow on the back of virtual care facilities.
Magellan Health's (MGLN) Arm Enhances Mental Health Solutions
by Zacks Equity Research
Magellan Health's (MGLN) behavioral and specialty health subsidiary introduces programs to help people deal with mental health illnesses amid festivities.
Centene (CNC) Acquires Apixio, Boosts Data Analytics Portfolio
by Zacks Equity Research
Centene (CNC) inks deal to acquire Apixio for availing enhanced AI technology solutions and digitizing its administrative activities.
Teladoc (TDOC) Q3 Earnings Beat Estimates, Hikes '20 Guidance
by Zacks Equity Research
Teladoc's (TDOC) third-quarter results reflect robust revenues and solid uptick in patient visits, partially offset by elevated costs.
Teladoc (TDOC) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Teladoc (TDOC) delivered earnings and revenue surprises of 60.61% and 2.58%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Will Covid-Led Higher Demand Aid Teladoc's (TDOC) Q3 Earnings?
by Zacks Equity Research
A surge in demand for virtual health care services is likely to have contributed to Teladoc's (TDOC) earnings in Q3
Centene (CNC) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Centene's (CNC) Q3 results are likely to reflect benefits from growing revenues and improving membership.
HCA Healthcare (HCA) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
HCA Healthcare's (HCA) third-quarter 2020 results are likely to reflect higher revenues owing to the gradual rise in patient volumes following the easing of government restrictions.
Teladoc (TDOC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed at $214.80 in the latest trading session, marking a -0.91% move from the prior day.
Teladoc's (TDOC) Telemedicine Service to Improve Mental Health
by Zacks Equity Research
Teladoc Health (TDOC) rolls out a new telemedicine solution to address mental health issues of Canadian employees.
Teladoc (TDOC) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Teladoc (TDOC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Tenet Healthcare's (THC) Earnings Beat in Q3, Improve Y/Y
by Zacks Equity Research
Tenet Healthcare's (THC) third-quarter earnings gain from the Ambulatory segment and lower expenses.
UnitedHealth (UNH) Up 33% in a Year: What's Aiding the Stock?
by Zacks Equity Research
UnitedHealth Group (UNH) continues to benefit from rolling out of cost-effective health plans and a strong balance sheet, which have been aiding its share price.
Teladoc (TDOC) Stock Moves -0.58%: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed at $230.45 in the latest trading session, marking a -0.58% move from the prior day.
UnitedHealth's (UNH) Earnings in Q3 Beat on Higher Revenues
by Zacks Equity Research
UnitedHealth's (UNH) Q3 earnings top estimates on solid revenues but the same was down year over year as health care utilization is resuming normalcy.
What's in the Offing for UnitedHealth (UNH) Earnings in Q3?
by Zacks Equity Research
UnitedHealth's (UNH) Q3 results are likely to reflect a rise in revenues but a decline in earnings.
Teladoc (TDOC) Stock Soars 166% YTD: More Room for Upside?
by Zacks Equity Research
Teladoc (TDOC) continues to benefit from increased telehealth visits and a strong balance sheet, which have been aiding its share price.
Teladoc (TDOC) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed at $225.21 in the latest trading session, marking a +1.63% move from the prior day.
UnitedHealth Arm Rolls Out Enhanced Health Plans for 2021
by Zacks Equity Research
UnitedHealth Group's (UNH) unit, UnitedHealthcare, reveals cost-effective health plans for 2021. This is likely to expand the company's U.S. footprint.
UnitedHealthcare's Health Plan to Aid Kansas City's Employers
by Zacks Equity Research
UnitedHealth Group's (UNH) business, UnitedHealthcare, rolls out a cost-effective health plan to benefit employers in the Kansas City area.
Teladoc (TDOC) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed at $217.34 in the latest trading session, marking a +1.05% move from the prior day.
Teladoc (TDOC) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed the most recent trading day at $202.66, moving -1.35% from the previous trading session.